PRESSEPORTAL Presseportal Logo

mehr Themen

Folgen
Keine Story von Hikma Pharmaceuticals PLC mehr verpassen.
Warum muss ich meine Email-Adresse eingeben?

Hikma Pharmaceuticals PLC

http://www.hikma.com

Filtern
  • 29.04.2022 – 19:43

    Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

    London (ots/PRNewswire) - Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK. About Hikma ...

    mehr
  • 10.01.2015 – 00:13

    Hikma to Launch Colchicine 0.6mg Capsules

    London (ots/PRNewswire) - Hikma Pharmaceuticals PLC ("Hikma") , the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the ...

    mehr